Rankings
▼
Calendar
VCEL Q2 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+32.2% YoY
Gross Profit
$9M
54.8% margin
Operating Income
-$3M
-14.9% margin
Net Income
-$2M
-14.1% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
+81.1%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$796,000
Balance Sheet
Total Assets
$37M
Total Liabilities
$23M
Stockholders' Equity
$14M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$13M
+32.2%
Gross Profit
$9M
$6M
+68.1%
Operating Income
-$3M
-$5M
+49.4%
Net Income
-$2M
-$3M
+21.6%
← FY 2017
All Quarters
Q3 2017 →